FENC

Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FENC

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/06	06 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/09/05	19 : 56	GlobeNewswire Inc.	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/09/05	07 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/09/05	07 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/09/05	05 : 05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/28	06 : 30	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/27	06 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/20	08 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/20	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/20	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/20	07 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/20	07 : 56	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/14	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/13	19 : 05	GlobeNewswire Inc.	Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/07	05 : 31	GlobeNewswire Inc.	Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/05	19 : 26	GlobeNewswire Inc.	Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/02	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/02	05 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/08/02	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/07/01	19 : 00	GlobeNewswire Inc.	Fennec Pharmaceuticals Announces Management Change	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/06/26	05 : 35	GlobeNewswire Inc.	Fennec Announces Results of Annual Meeting	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/06/04	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/06/04	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/06/04	05 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/05/22	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/05/22	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/05/22	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/05/15	06 : 24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/05/14	19 : 03	GlobeNewswire Inc.	Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:FENC	Fennec Pharmaceuticals Inc
2024/05/14	05 : 42	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:FENC	Fennec Pharmaceuticals Inc